General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Doxycycline hyclate USP reference standard suitable for use in specified USP compendial quality tests and assays.
Also used to prepare standard, system suitability stock, and sensitivity solution for the assay, impurity analysis, and performance test by using liquid chromatography in conjunction with UV detector according to the given below monographs of United States Pharmacopeia (USP):
- Doxycycline Hyclate
- Doxycycline Hyclate Delayed-Release Tablet
- Doxycycline Tablets
- Doxycycline Capsules
- Doxycycline Hyclate Tablets
Biochem/physiol Actions
Mode of Action: Doxycycline hyclate inhibits the inflammatory response to the Lyme Disease Spirochete Borrelia burgdorferi.
Activity Spectrum: Effective against a broad spectrum inhibitor of matrix metalloproteinases in vivo.
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. ​
Other Notes
USP issued SDS can be found here.
Sales restrictions may apply.
- UPC:
- 51284027
- Condition:
- New
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- 1226003-200MG